155 related articles for article (PubMed ID: 38347067)
21. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Li HB; Huang G; Tu J; Lv DM; Jin QL; Chen JK; Zou YT; Lee DF; Shen JN; Xie XB
EBioMedicine; 2022 Aug; 82():104142. PubMed ID: 35810559
[TBL] [Abstract][Full Text] [Related]
22. Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology.
Chen L; Zhou Y; Weng Z; Liu S; Li T; Wang Y; Yang Y; Liu H; Huang W
Aging (Albany NY); 2023 Oct; 15(20):11489-11507. PubMed ID: 37870753
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of
Ma N; Liu H; Wu Y; Yao M; Zhang B
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743017
[TBL] [Abstract][Full Text] [Related]
24. Immunoprecipitation and Sequencing of Acetylated RNA.
Arango D; Sturgill D; Oberdoerffer S
Bio Protoc; 2019 Jun; 9(12):e3278. PubMed ID: 33654795
[TBL] [Abstract][Full Text] [Related]
25. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
[TBL] [Abstract][Full Text] [Related]
26. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
28. Network pharmacology, molecular docking and bioinformatics reveal the mechanism of Tripterygii Wilfordii against Osteosarcoma.
Zhang Y; Wei J; Kong L; Song M; Zhang Y; Xiao X; Cao H; Jin Y
Medicine (Baltimore); 2022 Dec; 101(52):e32389. PubMed ID: 36595977
[TBL] [Abstract][Full Text] [Related]
29. Profile analysis of N4-acetylcytidine (ac4C) on mRNA of human lung adenocarcinoma and paired adjacent non-tumor tissues.
Shang X; Peng Y; Wang Y; Feng Z; Li M; Peng Z; Ren W
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130498. PubMed ID: 37890598
[TBL] [Abstract][Full Text] [Related]
30. NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells.
Dalhat MH; Mohammed MRS; Alkhatabi HA; Rehan M; Ahmad A; Choudhry H; Khan MI
Clin Transl Med; 2022 Sep; 12(9):e1045. PubMed ID: 36149760
[TBL] [Abstract][Full Text] [Related]
31. Epitranscriptomic profiling of N4-acetylcytidine-related RNA acetylation in the spinal dorsal horn of rat with cancer-induced bone pain.
Xu L; Zheng S; Liu B; Xu C; Yang L; Zhou Q; Yao M; Li XY
Mol Pain; 2023; 19():17448069231178487. PubMed ID: 37211783
[TBL] [Abstract][Full Text] [Related]
32. Use of network pharmacology and molecular docking to explore the mechanism of action of curcuma in the treatment of osteosarcoma.
Hu M; Yan H; Li H; Feng Y; Sun W; Ren Y; Ma L; Zeng W; Huang F; Jiang Z; Dong H
Sci Rep; 2023 Jun; 13(1):9569. PubMed ID: 37311820
[TBL] [Abstract][Full Text] [Related]
33. Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma.
Huang R; Xu M; Guo W; Cheng M; Dong R; Tu J; Xu S; Zou C
Cancer Cell Int; 2023 Sep; 23(1):213. PubMed ID: 37749554
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modiļ¬cation of the lymphocyte antigen six family member E (LY6E) mRNA.
Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W
J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284
[TBL] [Abstract][Full Text] [Related]
35. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
[No Abstract] [Full Text] [Related]
36. NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway.
Zhang Y; Deng Z; Sun S; Xie S; Jiang M; Chen B; Gu C; Yang Y
Front Oncol; 2022; 12():967811. PubMed ID: 35978804
[TBL] [Abstract][Full Text] [Related]
37. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
38. Integrated Analysis of Competing Endogenous RNAs Network Reveals Potential Signatures in Osteosarcoma Development.
Heng L; Jia Z; Sun J; Zhao Y; Zhang K; Zhu Y; Lu S
Technol Cancer Res Treat; 2020; 19():1533033820957025. PubMed ID: 32912111
[TBL] [Abstract][Full Text] [Related]
39. NAT10 mediated ac4C acetylation driven m
Mei Z; Shen Z; Pu J; Liu Q; Liu G; He X; Wang Y; Yue J; Ge S; Li T; Yuan Y; Yang L
Cell Commun Signal; 2024 Jan; 22(1):51. PubMed ID: 38233839
[TBL] [Abstract][Full Text] [Related]
40. Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma.
Xu K; Zhang P; Zhang J; Quan H; Wang J; Liang Y
Bioengineered; 2021 Dec; 12(1):3275-3293. PubMed ID: 34252359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
